627 related articles for article (PubMed ID: 28289035)
61. Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa.
Le Terrier C; Nordmann P; Freret C; Seigneur M; Poirel L
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0033923. PubMed ID: 37255469
[TBL] [Abstract][Full Text] [Related]
62. Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae.
Mushtaq S; Vickers A; Woodford N; Haldimann A; Livermore DM
J Antimicrob Chemother; 2019 Apr; 74(4):953-960. PubMed ID: 30590470
[TBL] [Abstract][Full Text] [Related]
63. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
Pfennigwerth N; Geis G; Gatermann SG; Kaase M
J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
[TBL] [Abstract][Full Text] [Related]
64. Changes to its peptidoglycan-remodeling enzyme repertoire modulate β-lactam resistance in Pseudomonas aeruginosa.
Cavallari JF; Lamers RP; Scheurwater EM; Matos AL; Burrows LL
Antimicrob Agents Chemother; 2013 Jul; 57(7):3078-84. PubMed ID: 23612194
[TBL] [Abstract][Full Text] [Related]
65. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
66. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
[TBL] [Abstract][Full Text] [Related]
67. Zidebactam restores sulbactam susceptibility against carbapenem-resistant
Cedano J; Baez M; Pasteran F; Montaña SD; Ra G; Fua V; Corso A; Tolmasky ME; Bonomo RA; Ramírez MS
Front Cell Infect Microbiol; 2022; 12():918868. PubMed ID: 35899052
[TBL] [Abstract][Full Text] [Related]
68. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
[TBL] [Abstract][Full Text] [Related]
69. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
70. Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Ito A; Nishikawa T; Ota M; Ito-Horiyama T; Ishibashi N; Sato T; Tsuji M; Yamano Y
J Antimicrob Chemother; 2018 Nov; 73(11):3049-3052. PubMed ID: 30188999
[TBL] [Abstract][Full Text] [Related]
71. Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.
Li XZ; Zhang L; Srikumar R; Poole K
Antimicrob Agents Chemother; 1998 Feb; 42(2):399-403. PubMed ID: 9527793
[TBL] [Abstract][Full Text] [Related]
72. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
[TBL] [Abstract][Full Text] [Related]
73. Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa.
Srikumar R; Tsang E; Poole K
J Antimicrob Chemother; 1999 Oct; 44(4):537-40. PubMed ID: 10588316
[TBL] [Abstract][Full Text] [Related]
74. Mutation of
Zhao X; Jin Y; Bai F; Cheng Z; Wu W; Pan X
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0042122. PubMed ID: 35695577
[TBL] [Abstract][Full Text] [Related]
75. Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model.
Asempa TE; Motos A; Abdelraouf K; Bissantz C; Zampaloni C; Nicolau DP
Int J Antimicrob Agents; 2020 Feb; 55(2):105838. PubMed ID: 31705960
[TBL] [Abstract][Full Text] [Related]
76. NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa.
Zamorano L; Reeve TM; Deng L; Juan C; Moyá B; Cabot G; Vocadlo DJ; Mark BL; Oliver A
Antimicrob Agents Chemother; 2010 Sep; 54(9):3557-63. PubMed ID: 20566764
[TBL] [Abstract][Full Text] [Related]
77. WCK 5222 (Cefepime/Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-lactamase producing
Lepak AJ; Zhao M; Andes DR
Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31591114
[TBL] [Abstract][Full Text] [Related]
78. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
Del Barrio-Tofiño E; López-Causapé C; Oliver A
Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
[TBL] [Abstract][Full Text] [Related]
79.
Karlowsky JA; Lob SH; Kazmierczak KM; Young K; Motyl MR; Sahm DF
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760135
[TBL] [Abstract][Full Text] [Related]
80. Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae.
López-Argüello S; Montaner M; Mármol-Salvador A; Velázquez-Escudero A; Docobo-Pérez F; Oliver A; Moya B
Microbiol Spectr; 2023 Jun; 11(3):e0069223. PubMed ID: 37093051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
